MARKSANS PHARMA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 188 INR | +13.22% |
|
+18.20% | +16.69% |
| 07-02 | Marksans Pharma Gets UK Regulator's Nod for Two Products | MT |
| 05-31 | Transcript : Marksans Pharma Limited, Q4 2024 Earnings Call, May 31, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MARKSANS PHARMA LIMITED | Other Pharmaceuticals | +13.22% | +18.20% | +16.69% | +100.63% | +876.57% | 1.02B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- MARKSANS Stock
- Charts Marksans Pharma Limited
- Comparison Chart
